Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01539317 · ADVERSE EVENTS

Adverse events

Therapy to Prevent Sexual Pain in Breast Cancer Survivors · Source last updated 2017-04-14

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.

Collection time frame
1 hour
Other-event reporting threshold
0%
Participants affected / participants at risk, as reported
Safety groupSerious eventsOther eventsDeaths
Topical Liquid Lidocaine

Topical liquid lidocaine: Comparison of topical liquid lidocaine to placebo on application to the vulvar vestibule

0 / 250 / 25Not reported / Not reported
Topical Saline

Topical liquid lidocaine: Comparison of topical liquid lidocaine to placebo on application to the vulvar vestibule

0 / 250 / 25Not reported / Not reported

Group identifiers: EG000: Topical Liquid Lidocaine · EG001: Topical Saline

Serious adverse events

Event terms and counts are source-reported; expand to read more. A reporting threshold may omit less frequent events.

    Other reported adverse events

    Event terms and counts are source-reported; expand to read more. A reporting threshold may omit less frequent events.

      Complete source fields
      event Groups
      1. description
        Topical liquid lidocaine: Comparison of topical liquid lidocaine to placebo on application to the vulvar vestibule
        id
        EG000
        other Num Affected
        0
        other Num At Risk
        25
        serious Num Affected
        0
        serious Num At Risk
        25
        title
        Topical Liquid Lidocaine
      2. description
        Topical liquid lidocaine: Comparison of topical liquid lidocaine to placebo on application to the vulvar vestibule
        id
        EG001
        other Num Affected
        0
        other Num At Risk
        25
        serious Num Affected
        0
        serious Num At Risk
        25
        title
        Topical Saline
      frequency Threshold
      0
      time Frame
      1 hour

      Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

      Preserved source evidence · Not medical advice